Please wait

Exhibit 107

CALCULATION OF FILING FEE TABLES

Form S-3

(Form Type)

Forte Biosciences, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

                 
     Security
Type
  Security
Class
Title
  Fee
Calculation
Rule
  Amount
Registered
  Proposed
Maximum
Offering
Price Per
Unit
  Maximum
Aggregate
Offering
Price
  Fee
Rate
  Amount of
Registration
Fee
 
Newly Registered Securities
                 

Fees to Be

Paid

  Equity   Common Stock, par value $0.001 per share   Rule 457(o)    (1)(2)   (3)   (3)   —    — 
                 

Fees to Be

Paid

  Equity   Preferred Stock, par value $0.001 per share   Rule 457(o)    (1)(2)   (3)   (3)   —    — 
                 

Fees to Be

Paid

  Debt   Debt Securities   Rule 457(o)    (1)(2)   (3)   (3)   —    — 
                 

Fees to Be

Paid

  Equity   Depositary Shares   Rule 457(o)    (1)(2)   (3)   (3)   —    — 
                 

Fees to Be

Paid

  Equity   Warrants   Rule 457(o)    (1)(2)   (3)   (3)   —    — 
                 

Fees to Be

Paid

  Other   Subscription Rights   Rule 457(o)    (1)(2)   (3)   (3)   —    — 
                 

Fees to Be

Paid

  Other   Purchase Contracts   Rule 457(o)    (1)(2)   (3)   (3)   —    — 
                 

Fees to Be

Paid

  Other   Units (4)   Rule 457(o)    (1)(2)   (3)   (3)   —    — 
                 

Fees to Be

Paid

  Unallocated (Universal) Shelf   Unallocated (Universal) Shelf   Rule 457(o)    (1)(2)   (3)   $300,000,000   $0.00015310   $45,930
           
    Total Offering Amounts     $300,000,000     $45,930
           
    Total Fees Previously Paid         — 
           
    Total Fee Offsets         $31,671
           
    Net Fee Due               $14,259

Table 2: Fee Offset Claims and Sources

 

                       
    

Registrant

or Filer

Name

  Form
or
Filing 
Type
 

File

Number

  Initial
Filing
Date
  Filing
Date
  Fee Offset
Claimed
 

Security

Type
Associated
with Fee
Offset
Claimed

  Security
Title
Associated
with Fee
Offset
Claimed
  Unsold
Securities
Associated
with Fee
Offset
Claimed
 

Unsold

Aggregate
Offering

Amount
Associated

with Fee

Offset

Claimed

 

Fee Paid

with Fee

Offset
Source

 
Rule 457(p)
                       

Fee Offset

Claims

  Forte Biosciences, Inc.   S-3   333-256611   May 28, 2021     $31,671 (5)  

Unallocated (Universal)

Shelf

  —    N/A   $290,300,000    
                       

Fee Offset

Sources

  Forte Biosciences, Inc.   S-3   333-256611       May 28, 2021                       $31,671

 

(1)

The securities registered consists of up to $300,000,000 of an indeterminate number of (a) shares of common stock, (b) shares of preferred stock, (c) debt securities, (d) depository shares, (e) warrants to purchase common stock, preferred stock or debt securities of the registrant, (f) subscription rights to purchase common stock, preferred stock, debt securities, warrants or units consisting of some or all of these securities of the registrant, (g) purchase contracts, and (h) units consisting of some or all of these securities, as may be sold from time to time by the registrant. There are also being registered hereunder an indeterminate number of shares of common stock and preferred stock as shall be issuable upon conversion, exchange or exercise of any securities that provide for such issuance.

(2)

Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, this registration statement shall also cover any additional shares of the registrant’s securities that become issuable by reason of any share splits, share dividends or similar transactions.

(3)

The proposed maximum per security and aggregate offering prices per class of securities will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security. Separate consideration may or may not be received for securities that are issuable on exercise, conversion or exchange of other securities, or that are issued in units.

(4)

Any securities registered under the registration statement may be sold separately or as units with other securities registered under the registration statement.

(5)

On May 28, 2021, the registrant filed a Registration Statement on Form S-3 (the “Prior Registration Statement”) registering up to $300,000,000 of the registrant’s common stock, preferred stock, debt securities, depository shares, warrants, subscription rights, purchase contracts and units and paying the associated filing fee. Of the $300,000,000 of securities registered with the Prior Registration Statement, $9,700,000 have been sold. The Prior Registration Statement expired on June 7, 2024, and therefore all offerings thereunder have been completed or terminated. As a result, the registrant has $290,300,000 of unsold securities and $31,671 in unused filing fees associated with the Prior Registration Statement. In accordance with Rule 457(p) under the Securities Act, the registrant is using the unused filing fees associated with the Prior Registration Statement to offset the filing fee payable in connection with this filing.